col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


111 Results       Page 1

 [1] 
American Medical Association: JAMA Oncology
  original article Date Title Authors   All Authors
1 [GO] 2023―Aug―31 Deaths Due to COVID-19 in Patients With Cancer During Different Waves of the Pandemic in the US Alexandra L. Potter, Vedha Vaddaraju, Shivaek Venkateswaran, Arian Mansur, Simar S. Bajaj, Mathew V. Kiang, et al. (+2)
2 [GO] 2023―Aug―17 Systemic Anticancer Therapy and Thromboembolic Outcomes in Hospitalized Patients With Cancer and COVID-19 Shuchi Gulati, Chih-Yuan Hsu, Surbhi Shah, Pankil K. Shah, Rebecca Zon, Susan Alsamarai, et al. (+450)
3 [GO] 2023―Jul―13 COVID-19 Severity and Waning Immunity After up to 4 mRNA Vaccine Doses in 73 608 Patients With Cancer and 621 475 Matched Controls in Singapore Wei Chong Tan, Janice Yu Jin Tan, Joline Si Jing Lim, Ryan Ying Cong Tan, Ainsley Ryan Yan Bin Lee, Fun Loon Leong, et al. (+13)
4 [GO] 2023―Jun―01 Approaches to Continuing COVID-19-Related Clinical Research Practices After the Pandemic-Must Cinderella Leave the Ball? David E. Gerber, Elizabeth K. S. Barksdale
5 [GO] 2023―Jun―01 Evidence Base for Health Care Strategies to Protect Vulnerable Patients During the COVID-19 Pandemic-Reply Michael Hoerger, James Gerhart, Maria C. Swartz
6 [GO] 2023―Jun―01 Evidence Base for Health Care Strategies to Protect Vulnerable Patients During the COVID-19 Pandemic Alyson Haslam, Vinay Prasad
7 [GO] 2023―May―11 Clinical Features and Risk Factors Associated With Multisystem Inflammatory Syndrome in Children With Cancer and COVID-19 Samantha D. Martin, Elizabeth S. Davis, Chen Dai, Lauren H. Boal, Brook Araya, Julienne Brackett, et al. (+114)
8 [GO] 2023―Apr―27 Assessment of Gender-Specific COVID-19 Case Fatality Risk per Malignant Neoplasm Type Koji Matsuo, Rachel S. Mandelbaum, Andrew Vallejo, Maximilian Klar, Lynda D. Roman, Jason D. Wright
9 [GO] 2023―Apr―27 Association of SARS-CoV-2 Antibody Level With Risk of Infection or Hospitalization-Reply Thomas Starkey, Michael Tilby, Lennard Y. W. Lee
10 [GO] 2023―Apr―27 Association of SARS-CoV-2 Antibody Level With Risk of Infection or Hospitalization Junyu Long, Peipei Chen, Haitao Zhao
11 [GO] 2022―Dec―29 Association of COVID-19 Vaccination With Breakthrough Infections and Complications in Patients With Cancer Inna Y. Gong, Abi Vijenthira, Melanie Powis, Andrew Calzavara, Aditi Patrikar, Rinku Sutradhar, et al. (+5)
12 [GO] 2022―Dec―22 Variability in COVID-19 Vaccine Response Among People With Cancer Michael Hoerger, James Gerhart, Maria C. Swartz
13 [GO] 2022―Dec―22 Association of SARS-CoV-2 Spike Protein Antibody Vaccine Response With Infection Severity in Patients With Cancer Lennard Y. W. Lee, Michael Tilby, Thomas Starkey, Maria C. Ionescu, Alex Burnett, Rosie Hattersley, et al. (+62)
14 [GO] 2022―Nov―17 Rates of Routine Cancer Screening and Diagnosis Before vs After the COVID-19 Pandemic Allison H. Oakes, Kelly Boyce, Catherine Patton, Sanjula Jain
15 [GO] 2022―Nov―03 Interplay of Immunosuppression and Immunotherapy Among Patients With Cancer and COVID-19 Ziad Bakouny, Chris Labaki, Punita Grover, Joy Awosika, Shuchi Gulati, Chih-Yuan Hsu, et al. (+478)
16 [GO] 2022―Oct―27 Reexamining Social Determinants of Health Data Collection in the COVID-19 Era Samyukta Mullangi, Emeline M. Aviki, Dawn L. Hershman
17 [GO] 2022―Oct―27 Analysis of Serious Adverse Event Reporting for Patients Enrolled in Cancer Clinical Trials During the COVID-19 Pandemic Meera V. Ragavan, Nichole Legaspi, Alyssa LaLanne, Julian C. Hong, Eric J. Small, Hala T. Borno
18 [GO] 2022―Sep―29 Identification of Deaths Caused by Cancer and COVID-19 in the US During March to December 2020 Xuesong Han, Xin Hu, Jingxuan Zhao, Ahmedin Jemal, K. Robin Yabroff
19 [GO] 2022―Sep―22 Inhibition of SARS-CoV-2 Omicron BA.1 and BA.4 Variants After Fourth Vaccination or Tixagevimab and Cilgavimab Administration in Patients With Cancer Maximilian J. Mair, Manfred Mitterer, Pia Gattinger, Julia M. Berger, Rudolf Valenta, Dominic Fong, Matthias Preusser
20 [GO] 2022―Aug―19 Antibody Response in Immunocompromised Patients With Hematologic Cancers Who Received a 3-Dose mRNA-1273 Vaccination Schedule for COVID-19 Sabine Haggenburg, Quincy Hofsink, Birgit I. Lissenberg-Witte, Annoek E. C. Broers, Jaap A. van Doesum, Rob S. van Binnendijk, et al. (+58)
21 [GO] 2022―Aug―04 SARS-CoV-2 Infections, Hospitalizations, and Mortality in Vaccinated Patients With Cancer in the US-Reply Rong Xu, Nathan A. Berger
22 [GO] 2022―Aug―04 SARS-CoV-2 Infections, Hospitalizations, and Mortality in Vaccinated Patients With Cancer in the US Renin Chang, Hui-Yuan Chen, Chih-Cheng Lai
23 [GO] 2022―Aug―04 SARS-CoV-2 Infections, Hospitalizations, and Mortality in Vaccinated Patients With Cancer in the US Binghao Zhao, Yu Xia, Wenbin Ma
24 [GO] 2022―Aug―04 SARS-CoV-2 Infections, Hospitalizations, and Mortality in Vaccinated Patients With Cancer in the US Yung-Shuo Kao, James Cheng-Chung Wei, Chih-Jung Yeh
25 [GO] 2022―Jul―07 Global Association of COVID-19 Pandemic Measures With Cancer Screening Federica Teglia, Marco Angelini, Laura Astolfi, Giulia Casolari, Paolo Boffetta
26 [GO] 2022―Jun―23 Environmental Outcomes Associated With Transition From In-Person to a Virtual Oncology Conference During the COVID-19 Pandemic Katie E. Lichter, Taylor Drew, Sasha Demeulenaere, Emily Wong, Osama Mohamad, Sue S. Yom, Hilary P. Bagshaw
27 [GO] 2022―Apr―21 Evaluation of the Durability of the Immune Humoral Response to COVID-19 Vaccines in Patients With Cancer Undergoing Treatment or Who Received a Stem Cell Transplant Qamar J. Khan, Cory R. Bivona, Grace A. Martin, Jun Zhang, Ben Liu, Jianghua He, et al. (+20)
28 [GO] 2022―Apr―08 Breakthrough SARS-CoV-2 Infections, Hospitalizations, and Mortality in Vaccinated Patients With Cancer in the US Between December 2020 and November 2021 William Wang, David C. Kaelber, Rong Xu, Nathan A. Berger
29 [GO] 2022―Apr―07 Association of the COVID-19 Pandemic With Rates of Prostate Cancer Biopsies and Diagnoses in Black vs White US Veterans Zachary Klaassen, Shannon Stock, Justin Waller, Amanda De Hoedt, Stephen J. Freedland
30 [GO] 2022―Mar―10 Humoral Responses Against Variants of Concern by COVID-19 mRNA Vaccines in Immunocompromised Patients Michel Obeid, Madeleine Suffiotti, Celine Pellaton, Hasna Bouchaab, Anne Cairoli, Vanja Salvadé, et al. (+13)
31 [GO] 2022―Mar―10 Evaluation of Antibody Response to SARS-CoV-2 mRNA-1273 Vaccination in Patients With Cancer in Florida Anna R. Giuliano, Jeffrey E. Lancet, Shari Pilon-Thomas, Ning Dong, Akriti G. Jain, Elaine Tan, et al. (+10)
32 [GO] 2022―Jan―07 SARS-CoV-2 Antibody Response to 2 or 3 Doses of the BNT162b2 Vaccine in Patients Treated With Anticancer Agents Charlotte Fenioux, Luis Teixeira, Slim Fourati, Giovanna Melica, Jean Daniel Lelievre, Sebastien Gallien, et al. (+3)
33 [GO] 2021―Dec―02 Neutralizing Antibody Testing in Patients With Multiple Myeloma Following COVID-19 Vaccination Evangelos Terpos, S. Vincent Rajkumar, Nelson Leung
34 [GO] 2021―Dec―02 Association of COVID-19 Vaccination With SARS-CoV-2 Infection in Patients With Cancer Julie Tsu-Yu Wu, Jennifer La, Westyn Branch-Elliman, Linden B. Huhmann, Summer S. Han, Giovanni Parmigiani, et al. (+6)
35 [GO] 2021―Nov―24 Time-Dependent COVID-19 Mortality in Patients With Cancer David J. Pinato, Meera Patel, Lorenza Scotti, Emeline Colomba, Saoirse Dolly, Angela Loizidou, et al. (+74)
36 [GO] 2021―Nov―23 Assessment of Response to a Third Dose of the SARS-CoV-2 BNT162b2 mRNA Vaccine in Patients With Solid Tumors Undergoing Active Treatment Yakir Rottenberg, Albert Grinshpun, Iddo Z. Ben-Dov, Esther Oiknine Djian, Dana G. Wolf, Luna Kadouri
37 [GO] 2021―Nov―18 SARS-CoV-2 Spike-Specific T-Cell Responses in Patients With B-Cell Depletion Who Received Chimeric Antigen Receptor T-Cell Treatments Kalpana Parvathaneni, Kyabeth Torres-Rodriguez, Wenzhao Meng, Wei-Ting Hwang, Noelle Frey, Ali Naji, Vijay G. Bhoj
38 [GO] 2021―Oct―28 Evaluation of COVID-19 Mortality and Adverse Outcomes in US Patients With or Without Cancer Mariana Chavez-MacGregor, Xiudong Lei, Hui Zhao, Paul Scheet, Sharon H. Giordano
39 [GO] 2021―Sep―30 Humoral Immune Response in Hematooncological Patients and Health Care Workers Who Received SARS-CoV-2 Vaccinations Maximilian J. Mair, Julia M. Berger, Anna S. Berghoff, Angelika M. Starzer, Gregor Ortmayr, Hannah C. Puhr, et al. (+11)
40 [GO] 2021―Sep―02 COVID-19 and Cancer Aakash Desai, Turab J. Mohammed, Narjust Duma, Marina C. Garassino, Lisa K. Hicks, Nicole M. Kuderer, et al. (+9)
41 [GO] 2021―Aug―19 Association of Convalescent Plasma Therapy With Survival in Patients With Hematologic Cancers and COVID-19 Michael A. Thompson, Jeffrey P. Henderson, Pankil K. Shah, Samuel M. Rubinstein, Michael J. Joyner, Toni K. Choueiri, et al. (+275)
42 [GO] 2021―Aug―19 Use of an Analytics and Electronic Health Record-Based Approach for Targeted COVID-19 Vaccine Outreach to Marginalized Populations Jacob Stein, Megan Fasold, Karyn Jean Daguerre, Jaime Richardson, Summer Cheek, Marjory Charlot, Ethan Basch
43 [GO] 2021―Aug―19 Association of Antineoplastic Therapy With Decreased SARS-CoV-2 Infection Rates in Patients With Cancer Michael B. Foote, James Robert White, Justin Jee, Guillem Argilés, Jonathan C. M. Wan, Benoit Rousseau, et al. (+2)
44 [GO] 2021―Aug―11 Antibody Response to COVID-19 Vaccination in Adults With Hematologic Malignant Disease Thomas A. Ollila, Shaolei Lu, Rebecca Masel, Adam Zayac, Kimberly Paiva, Ralph D. Rogers, Adam J. Olszewski
45 [GO] 2021―Aug―11 Durability of Response to SARS-CoV-2 BNT162b2 Vaccination in Patients on Active Anticancer Treatment Noa Eliakim-Raz, Amir Massarweh, Amos Stemmer, Salomon M. Stemmer
46 [GO] 2021―Jul―22 Assessment of Prostate Cancer Treatment Among Black and White Patients During the COVID-19 Pandemic Adrien N. Bernstein, Ruchika Talwar, Elizabeth Handorf, Kaynaat Syed, John Danella, Serge Ginzburg, et al. (+12)
47 [GO] 2021―Jul―22 Incidence of Axillary Adenopathy in Breast Imaging After COVID-19 Vaccination Kristin A. Robinson, Santo Maimone, Denise A. Gococo-Benore, Zhuo Li, Pooja P. Advani, Saranya Chumsri
48 [GO] 2021―Jul―08 Serologic Status and Toxic Effects of the SARS-CoV-2 BNT162b2 Vaccine in Patients Undergoing Treatment for Cancer Tal Goshen-Lago, Ithai Waldhorn, Roy Holland, Moran Szwarcwort-Cohen, Anat Reiner-Benaim, Yael Shachor-Meyouhas, et al. (+8)
49 [GO] 2021―Jun―17 Time-Related Biases in Nonrandomized COVID-19-Era Studies Using Real-world Data Gregory S. Calip, Rebecca A. Miksad, Somnath Sarkar
50 [GO] 2021―Jun―10 Association of COVID-19 mRNA Vaccine With Ipsilateral Axillary Lymph Node Reactivity on Imaging Mehmet Emin Adin, Edvin Isufi, Michal Kulon, Darko Pucar
51 [GO] 2021―Jun―10 Attitudes and Factors Associated With COVID-19 Vaccine Hesitancy Among Patients With Breast Cancer Cynthia Villarreal-Garza, Bryan F. Vaca-Cartagena, Andrea Becerril-Gaitan, Ana S. Ferrigno, Fernanda Mesa-Chavez, Alejandra Platas, Ana Platas
52 [GO] 2021―May―28 Difference in SARS-CoV-2 Antibody Status Between Patients With Cancer and Health Care Workers During the COVID-19 Pandemic in Japan Shu Yazaki, Tatsuya Yoshida, Yuki Kojima, Shigehiro Yagishita, Hiroko Nakahama, Keiji Okinaka, et al. (+14)
53 [GO] 2021―May―28 Immune Responses to SARS-CoV-2 Among Patients With Cancer Lova Sun, Jeremy L. Warner, Ravi B. Parikh
54 [GO] 2021―May―28 Evaluation of Seropositivity Following BNT162b2 Messenger RNA Vaccination for SARS-CoV-2 in Patients Undergoing Treatment for Cancer Amir Massarweh, Noa Eliakim-Raz, Amos Stemmer, Adva Levy-Barda, Shlomit Yust-Katz, Alona Zer, et al. (+9)
55 [GO] 2021―May―20 Accompanying Patients in the Time of COVID-19 Joseph O. Jacobson
56 [GO] 2021―May―13 COVID-19 Vaccines in Patients With Cancer-A Welcome Addition, but There Is Need for Optimization Eleni Korompoki, Maria Gavriatopoulou, Dimitrios P. Kontoyiannis
57 [GO] 2021―May―07 Risk, Racial Disparity, and Outcomes Among Patients With Cancer and COVID-19 Infection Julie A. Wolfson, Emily E. Johnston, Kelly M. Kenzik
58 [GO] 2021―May―07 Risk, Racial Disparity, and Outcomes Among Patients With Cancer and COVID-19 Infection Vaibhav Kumar, Megan Grant, Karlyn A. Martin
59 [GO] 2021―May―07 Risk, Racial Disparity, and Outcomes Among Patients With Cancer and COVID-19 Infection-Reply Rong Xu, Nathan A. Berger, QuanQiu Wang
60 [GO] 2021―Apr―29 Association of Cancer Screening Deficit in the United States With the COVID-19 Pandemic Ronald C. Chen, Kevin Haynes, Simo Du, John Barron, Aaron J. Katz
61 [GO] 2021―Mar―18 Last Christmas-Counseling Patients in the Era of COVID-19 Christopher E. Jensen
62 [GO] 2021―Feb―11 Pragmatic Solutions to Counteract the Regressive Effects of the COVID-19 Pandemic for Women in Academic Oncology Bridget Keenan, Reshma Jagsi, Katherine Van Loon
63 [GO] 2021―Jan―21 The Role of Temozolomide in Patients With Newly Diagnosed Wild-Type IDH, Unmethylated MGMTp Glioblastoma During the COVID-19 Pandemic David O. Kamson, Stuart A. Grossman
64 [GO] 2021―Jan―14 Cancer Screening Tests and Cancer Diagnoses During the COVID-19 Pandemic Ziad Bakouny, Marco Paciotti, Andrew L. Schmidt, Stuart R. Lipsitz, Toni K. Choueiri, Quoc-Dien Trinh
65 [GO] 2021―Jan―13 Implementation and Outcomes of Virtual Care Across a Tertiary Cancer Center During COVID-19 Alejandro Berlin, Mike Lovas, Tran Truong, Sheena Melwani, Justin Liu, Zhihui Amy Liu, et al. (+13)
66 [GO] 2020―Dec―23 FDA Oncology Center of Excellence During COVID-19-Working for Patients With Cancer Jennifer J. Gao, Richard Pazdur
67 [GO] 2020―Dec―18 COVID-19 and Social Distancing Efforts-Implications for Cancer Control Rebecca A. Ferrer, Amanda M. Acevedo, Tanya D. Agurs-Collins
68 [GO] 2020―Dec―18 Incidence of SARS-CoV-2 Infection Among Patients Undergoing Active Antitumor Treatment in Italy Carlo Aschele, Maria Emanuela Negru, Alessandro Pastorino, Luigi Cavanna, Vittorina Zagonel, Francesco Barone-Adesi, Livio Blasi
69 [GO] 2020―Dec―10 Scientific Rigor in the Age of COVID-19 Yu Shyr, Lynne D. Berry, Chih-Yuan Hsu
70 [GO] 2020―Dec―10 Use of Real-World Electronic Health Records to Estimate Risk, Risk Factors, and Disparities for COVID-19 in Patients With Cancer Aakash Desai, Ali Raza Khaki, Nicole M. Kuderer
71 [GO] 2020―Dec―10 Analyses of Risk, Racial Disparity, and Outcomes Among US Patients With Cancer and COVID-19 Infection QuanQiu Wang, Nathan A. Berger, Rong Xu
72 [GO] 2020―Dec―03 How Will Patients With Cancer Fare During COVID-19? Beth A. Virnig, Sayeh S. Nikpay
73 [GO] 2020―Nov―25 Perceived Care and Well-being of Patients With Cancer and Matched Norm Participants in the COVID-19 Crisis Lonneke V. van de Poll-Franse, Belle H. de Rooij, Nicole J. E. Horevoorts, Anne M. May, Geraldine R. Vink, Miriam Koopman, et al. (+12)
74 [GO] 2020―Nov―25 New Approaches to Cancer Care in a COVID-19 World-The Role of Health and Social Protection Policies Reena Patel, Lisa Pickering, Mehran Afshar
75 [GO] 2020―Nov―12 Association of the COVID-19 Outbreak With Patient Willingness to Enroll in Cancer Clinical Trials Mark E. Fleury, Amy M. Farner, Joseph M. Unger
76 [GO] 2020―Nov―05 Serial Screening for COVID-19 in Asymptomatic Patients Receiving Anticancer Therapy in the United Arab Emirates Humaid O. Al-Shamsi, Eric A. Coomes, Khuloud Aldhaheri, Sadir Alrawi
77 [GO] 2020―Oct―29 Integrated Survival Estimates for Cancer Treatment Delay Among Adults With Cancer During the COVID-19 Pandemic Holly E. Hartman, Yilun Sun, Theresa P. Devasia, Elizabeth C. Chase, Neil K. Jairath, Robert T. Dess, et al. (+12)
78 [GO] 2020―Oct―29 To Treat or Not to Treat-Balancing Benefits and Risks of Treatment Delay Among Patients With Cancer During the COVID-19 Pandemic Elizabeth Garrett-Mayer, Brian I. Rini
79 [GO] 2020―Oct―22 Independent Oncology Practices in the COVID-19 Era-Does US Cancer Care Need a Bailout? Zachary A. K. Frosch, Lawrence N. Shulman, Justin E. Bekelman
80 [GO] 2020―Oct―15 Important Concerns Over SARS-CoV-2 Infection in Children With Cancer Lipeng Zhang, Danni He, Wenquan Niu
81 [GO] 2020―Oct―15 Important Concerns Over SARS-CoV-2 Infection in Children With Cancer-Reply Andrew L. Kung, Audrey Mauguen, Farid Boulad
82 [GO] 2020―Oct―08 US Food and Drug Administration Support for Oncology Drug Development During COVID-19 Kushal T. Kadakia, Richard Pazdur, Anand Shah
83 [GO] 2020―Sep―17 Changes in Lung Cancer Treatment as a Result of the Coronavirus Disease 2019 Pandemic Arielle Elkrief, Suzanne Kazandjian, Nathaniel Bouganim
84 [GO] 2020―Sep―03 The Day After COVID-19-Time to Rethink Oncology Clinical Research Daniel V. Araujo, Geoffrey A. Watson, Lillian L. Siu
85 [GO] 2020―Aug―27 Caring for Patients With Cancer in the Face of Self-Vulnerability During the COVID-19 Pandemic J. Isabelle Choi, Charles B. Simone
86 [GO] 2020―Aug―27 Caring for Patients With Cancer in the Face of Self-Vulnerability During the COVID-19 Pandemic-Reply Coral Olazagasti, Nagashree Seetharamu
87 [GO] 2020―Aug―27 Prevalence of Surface Contamination With SARS-CoV-2 in a Radiation Oncology Clinic Imraan Jan, Kenneth Chen, Mutlay Sayan, Priyanka Uprety, Robert J. Laumbach, Ronald D. Ennis, Bruce G. Haffty
88 [GO] 2020―Aug―14 Relative Timing of Radiotherapy and Androgen Deprivation for Prostate Cancer and Implications for Treatment During the COVID-19 Pandemic Edward Christopher Dee, Brandon A. Mahal, Melaku A. Arega, Anthony V. D’Amico, Kent W. Mouw, Paul L. Nguyen, Vinayak Muralidhar
89 [GO] 2020―Aug―14 Disparities in Cancer Outcomes Due to COVID-19-A Tale of 2 Cities Onyinye D. Balogun, Vivian J. Bea, Erica Phillips
90 [GO] 2020―Aug―06 Rethinking Clinical Trials Reform During the COVID-19 Pandemic Chadi Nabhan, Toni K. Choueiri, Anthony R. Mato
91 [GO] 2020―Aug―06 Perspectives on Oncology-Specific Language During the Coronavirus Disease 2019 Pandemic Laila A. Gharzai, Kenneth Resnicow, Lawrence C. An, Reshma Jagsi
92 [GO] 2020―Aug―06 Applying Lessions Learned From Low-Resource Settings to Prioritize Cancer Care in a Pandemic Rebecca J. DeBoer, Temidayo A. Fadelu, Lawrence N. Shulman, Katherine Van Loon
93 [GO] 2020―Jul―30 Outcomes in Radiotherapy-Treated Patients With Cancer During the COVID-19 Outbreak in Wuhan, China Conghua Xie, Xiaoyong Wang, Hui Liu, Zhirong Bao, Jing Yu, Yahua Zhong, Melvin L. K. Chua
94 [GO] 2020―Jul―23 Distancing Without Isolating-Connection in the Era of COVID-19 Kiri A. Cook, Jenna M. Kahn
95 [GO] 2020―Jul―23 Managing Grief, Loss, and Connection in Oncology-What COVID-19 Has Taken Hanna K. Sanoff
96 [GO] 2020―Jul―16 Telemedicine for Cancer Care in the Time of COVID-19 Trevor J. Royce, Hanna K. Sanoff, Amar Rewari
97 [GO] 2020―Jul―02 Risk of COVID-19 in Patients With Cancer Andrew Robinson, Bishal Gyawali, Christopher M. Booth
98 [GO] 2020―Jul―02 Risk of COVID-19 in Patients With Cancer Michael L. Maitland, David Heyer, Mardi Gomberg-Maitland
99 [GO] 2020―Jul―02 Risk of COVID-19 in Patients With Cancer Tim Johannes Adrianus Dekker
100 [GO] 2020―Jul―02 Risk of COVID-19 in Patients With Cancer Ling Peng, Fei Liang, Yang Xia
101 [GO] 2020―Jul―02 Risk of COVID-19 in Patients With Cancer-Reply Melvin L. K. Chua, Jing Yu, Conghua Xie
102 [GO] 2020―Jul―02 Covid-19 Pandemic-An Opportunity to Reduce and Eliminate Low-Value Practices in Oncology? Bishal Gyawali, Bishesh Sharma Poudyal, Elizabeth A. Eisenhauer
103 [GO] 2020―Jun―18 Implications for Design and Analyses of Oncology Clinical Trials During the COVID-19 Pandemic Chaya S. Moskowitz, Katherine S. Panageas
104 [GO] 2020―May―27 Weight-Based Dosing of Pembrolizumab Every 6 Weeks in the Time of COVID-19 Daniel A. Goldstein, Mark J. Ratain, Leonard B. Saltz
105 [GO] 2020―May―27 Screening for COVID-19 in Asymptomatic Patients With Cancer in a Hospital in the United Arab Emirates Humaid O. Al-Shamsi, Eric A. Coomes, Sadir Alrawi
106 [GO] 2020―May―20 Coronavirus Disease 2019 (COVID-19) and Immune-Engaging Cancer Treatment Muhammad Bilal Abid, Mustafa Mughal, Muhammad Abbas Abid
107 [GO] 2020―May―14 COVID-19 in Children With Cancer in New York City Farid Boulad, Mini Kamboj, Nancy Bouvier, Audrey Mauguen, Andrew L. Kung
108 [GO] 2020―Apr―24 Facing a Pandemic While Pregnant Coral Olazagasti, Nagashree Seetharamu
109 [GO] 2020―Apr―10 Caring for Patients With Cancer During the COVID-19 Outbreak in Italy Filippo Pietrantonio, Marina Chiara Garassino
110 [GO] 2020―Apr―01 Active and Effective Measures for the Care of Patients With Cancer During the COVID-19 Spread in China Zhijie Wang, Jie Wang, Jie He
111 [GO] 2020―Mar―25 SARS-CoV-2 Transmission in Patients With Cancer at a Tertiary Care Hospital in Wuhan, China Jing Yu, Wen Ouyang, Melvin L. K. Chua, Conghua Xie
 [1] 

111 Results       Page 1



[de][en]

Last change 2023―Apr―13 19:50:14 UTC

© Daten-Quadrat 2022       Done in 0.014 sec